<DOC>
	<DOCNO>NCT00409318</DOCNO>
	<brief_summary>This study investigate whether blockade TNF result reduce inflammatory index patient metabolic syndrome</brief_summary>
	<brief_title>Study TNF-Antagonism Metabolic Syndrome</brief_title>
	<detailed_description>Metabolic syndrome increasingly prevalent disorder associate elevated risk type II DM ( diabetes mellitus ) cardiovascular morbidity mortality . A subclinical inflammatory state think contribute pathophysiology metabolic syndrome , insulin resistance , coronary artery disease ( CAD ) . TNF-alpha inflammatory cytokine increase spectrum inflammatory disease well insulin resistance . TNF-alpha antagonist clinically effective inflammation arthritides , examine metabolic syndrome population . Moreover , data suggests adiponectin , recently discover adipocytokine may protect development insulin resistance atherosclerosis , may downregulated TNF-alpha . We propose study administer etanercept , TNF-alpha receptor fusion protein , subject metabolic syndrome examine effect inflammatory marker , CRP , adiponectin insulin resistance . This would first study investigate anti-inflammatory property insulin sensitize potential TNF-alpha blockade grow population metabolic syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Inclusion Criteria base modify WHO definition metabolic syndrome 1 . Hyperinsulinemia upper quartile nondiabetic population define &gt; = 10 mU/mL ( Framingham Data , oral communication , James Meigs , MD ) fast glucose 110126 mg/dL Plus two following : 2 . Abdominal obesity define waist hip ratio &gt; 0.90 men &gt; 0.85 woman BMI &gt; 30 kg/m2 3 . Dyslipidemia include serum triglyceride ³ 150 mg/dl serum HDL &lt; 0.9 mmol/L men ( 35 mg/dL ) &lt; 1.0 mmol/L ( 39mg/dL ) woman 4 . Hypertension define blood pressure &gt; = 140/90 medication 1 . Positive PPD ( ³ 5mm induration ) screen 2 . Current Infection 3 . Therapy glucocorticoid immunosuppressant time recruitment within past 3 month 4 . Reception live vaccine within 1 week recruitment 5 . History blood dyscrasia include kind anemia , thrombocytopenia , pancytopenia . Women reversible cause anemia resolve eligible . 6 . History malignancy ( except patient surgically cure basal cell squamous cell skin cancer eligible ) 7 . History organ transplantation 8 . History CNS demyelinate disorder first degree relative multiple sclerosis 9 . History CHF class IIV 10 . Current use insulin , oral antihyperglycemic agent , pentoxyfylline , betaagonists 11 . Current use fibrate niacin 12 . Initiation statin therapy within prior 6 week expect change statin dose upcoming 3 month 13 . Hemoglobin &lt; 11 g/dl 14 . Positive pregnancy test 15 . Women childbearing potential currently use nonhormonal birth control method include barrier method ( IUD , condom , diaphragm ) abstinence 16 . Patients know autoimmune inflammatory condition ( exclude patient stable , treated hypothyroidism )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Visceral adiposity</keyword>
	<keyword>TNF</keyword>
	<keyword>CRP</keyword>
	<keyword>Adiponectin</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>